Dorval Allison

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Dorval Allison's trades of Puma Biotechnology Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-06-17 2025-06-13 PlS Planned sale
96,633 -25.3%
28.46
US$2,358,200
96,633 -25.3% 28.46 US$2,358,200
2025-06-13 2025-06-13 PrS Proposed sale
81,925
250.99
US$1,493,308
81,925 250.99 US$1,493,308
2025-04-03 2025-04-02 S Sale
85,148 -26.8%
374.92
US$3,124,519
85,148 -26.8% 374.92 US$3,124,519
2024-12-03 2024-12-02 S Sale
555 -9.4%
5.64
US$3,130
555 -9.4% 5.64 US$3,130
2024-06-17 2024-06-13 PlS Planned sale
11,000 -25.0%
3.37
US$37,096
11,000 -25.0% 3.37 US$37,096
2024-06-13 2024-06-13 PrS Proposed sale
11,000
3.60
US$39,545
11,000 3.60 US$39,545
2023-12-01 2023-11-29 S Sale
554 -12.0%
11.45
US$6,343
554 -12.0% 11.45 US$6,343
2023-06-15 2023-06-13 PlS Planned sale
10,000 -37.0%
3.45
US$34,500
10,000 -37.0% 3.45 US$34,500
2023-06-13 2023-06-13 PrS Proposed sale
10,000
3.46
US$34,600
10,000 3.46 US$34,600
2022-12-01 2022-11-29 S Sale
554 -20.2%
22.10
US$12,243
554 -20.2% 22.10 US$12,243
2021-02-16 2021-02-11 PlS Planned sale
3,186 -6.5%
7.55
US$24,054
3,186 -6.5% 7.55 US$24,054
2021-01-14 2021-01-12 PlS Planned sale
2,942 -5.7%
8.62
US$25,360
2,942 -5.7% 8.62 US$25,360
2020-01-29 2020-01-21 PlS Planned sale
3,128 -11.3%
13.36
US$41,790
3,128 -11.3% 13.36 US$41,790